Skip to content
Keyword
Name
Filter your search:
All
Services & Industries
Experience
Insights
News
Others
Filter your search:
Search All
Services
Experience
Insights
Professionals
Services
Industries
Insights
Trending Topics
About
Locations
Careers
Search
Close
Menu
Close
发表文章
September 05, 2018
SCOTUS to Weigh in on Pharmaceutical Conflict Preemption in
Fosamax
Case
Email
Facebook
LinkedIn
Twitter
Authors:
Joe Winebrenner
Elie C. Biel
Joe Winebrenner
and
Elie Biel
co-authored an article for the American Bar Association, which analyzed a prescription drug, product-liability case being heard in the Supreme Court of the United States.
Full Article
作者
Joe Winebrenner
Counsel
Minneapolis
+1 612 766 8930
joe.winebrenner@faegredrinker.com
Elie C. Biel
Associate
Minneapolis
+1 612 766 8407
elie.biel@faegredrinker.com
SCOTUS to Weigh in on Pharmaceutical Conflict Preemption in Fosamax Case | Publications | Insights | Faegre Drinker Biddle & Reath LLP
https://www.faegredrinker.com/-/media/images/professionals/no_photo_placeholder.jpg?rev=05c30bad7b8d4ea7ad0c651ad1851738&hash=260633C7701BB47FD3D22AB23C3B7A33
SCOTUS to Weigh in on Pharmaceutical Conflict Preemption in Fosamax Case | Publications | Insights | Faegre Drinker Biddle & Reath LLP
https://www.faegredrinker.com/-/media/images/professionals/no_photo_placeholder.jpg?rev=05c30bad7b8d4ea7ad0c651ad1851738&hash=260633C7701BB47FD3D22AB23C3B7A33